The Biden administration has proposed a plan for Medicare and Medicaid to offer coverage for weight loss medications, such as ...

The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and ...

Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' ...

Dr. Caroline Apovian says you can still enjoy the holidays and festive meals while you're taking GLP-1 medications if you ...

Robby Soave and Niall Stanage weigh in on how Robert F. Kennedy Jr. will impact the booming popularity of weight loss drugs.

Amgen's experimental drug MariTide helped overweight or obese patients shed up to 20% of their body weight in a mid-stage ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

Major stock indexes were mixed in midday trading Tuesday as investors digested earnings reports from several retailers and ...

Does Ozempic cause hair loss? I asked a board-certified OB/GYN about why some folks on GLP-1 medications like Ozempic, Wegovy ...

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new Biden administration rule.

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...